- The share
- Press releases
- Financial calendar
- Financial reports
- Financial reports – ESEF
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Environmental Policy
- Code of Conduct for Suppliers
- Contact us
- Thank you
Share warrant program fully subscribed
XVIVO Perfusion AB's share warrant program 2014/2016 is fully subscribed. A total of 195,000 warrants with the right to subscribe for new shares were issued. Each warrant has in June 2016 the right to subscribe for one new share at a price of SEK 58.60.
The annual shareholder meeting April 29, 2014 approved the warrant program of a maximum of 195,000 warrants to be offered to all employees in XVIVO Perfusion AB. Upon full exercise of the warrants, the share capital increase is SEK 5,000 corresponding to a dilution of about 1 percent of the total number of shares and votes.
Magnus Nilsson, CEO of XVIVO Perfusion: “The broad support is very encouraging and it gives all of our employees a stronger shareholder interest and an even stronger incentive to fulfill our goals.”
July 7, 2014
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 31 788 21 59, email@example.com
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
The information was submitted for publication on July 7, 2014 at 8:30 a.m.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.